January 6, 2026, Chiyoda-ku, Tokyo — PeptiGrowth Inc. (Headquarters: Chiyoda-ku, Tokyo, President: Jun Minamitani) has successfully developed a novel synthetic peptide called “IL-15 alternative peptide” which is functionally equivalent to recombinant interleukin 15 (IL-15). This product will be on the market in December 2025. [Read more…]
4 Major Areas of Commercialization for iPS Cells
Since the discovery of induced pluripotent stem cells in 2006, a great deal of basic research has been done to understand how to produce, manipulate, and utilize the stem cell type. In addition to this important basic research, a great deal of applied (“translational”) results has been done with the cell type. Induced pluripotent stem cells (also called iPS cells or iPSCs) are revolutionizing regenerative medicine because they represent a potential route for producing patient-specific stem cells for research or clinical use.
In the future, iPS cells will facilitate progress in personalized medicine by allowing a patient to use his or her own cells. In addition, iPSCs also show great promise in other areas, such as phamaco-toxicological screening, by allowing disease modeling and safety assessment of potential new drugs under development, in short, facilitating the study of a “disease in a dish.”
AABB To Run Limited-Time Certified Advanced Biotherapies Professional (CABP) Free Exam Retake Offer
December 2, 2025, Bethesda, MD – The Association for the Advancement of Blood & Biotherapies (AABB) is pleased to announce a limited-time Certified Advanced Biotherapies Professional (CABP) free exam retake offer, supporting prospective CABPs looking to pursue the credential and take their biotherapies expertise to the next level in 2026.
- Starting December 1, 2025, AABB is running a limited-time offer to approved CABP applicants: Candidates who submit their CABP application before midnight on Jan. 9, 2026, will receive a free CABP exam retake voucher (usually $150).
- Additionally, approved applicants will also receive complimentary access to AABB’s CABP Exam Prep Bootcamps video series (a $275 value). Developed by a diverse panel of credentialed CABPs and experts in the biotherapies field, each pre-recorded bootcamp focuses on one of the seven domains covered in the CABP exam. Each bootcamp also includes the presenter’s handouts and a downloadable audio file. The complimentary “Getting Started with CABP” bootcamp includes a self-assessment tool, study plan tool and a study group planner.
BBG Advanced Therapies collects first cell donation on one-of-a-kind bus
New vehicle to help enable lifesaving new advanced therapies
The world’s only mobile leukapheresis center recorded its first donation on Monday, Oct. 20, marking the beginning of a new era for global healthcare.
The BBG Advanced Therapies mobile leukapheresis center, the first of its kind in the world, can help improve access to lifesaving treatments across an area of almost 70,000 square miles currently underserved by next-generation advanced therapies. [Read more…]
MSCs: Why We’re Not There Yet—and What’s Next with Dr. Daniel Kota
In this article, Dr. Daniel Kota provides a mesenchymal stem cell review and explores the future of MSC therapy. Mesenchymal stem cells (MSCs) are multipotent cells that prefer to differentiate into cells of the musculoskeletal system, such as bone, cartilage, muscle and fat cells. However, MSCs can also be induced to become other cell types, as well as exert therapeutic effects by honing to sites of repair and secreting therapeutic agents.
In this article:
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 19
- Next Page »